Making Gender endeavours to understand how the HPV vaccine became gendered within the Canadian policy landscape - when the virus is gender blind and is linked to cancer in all genders - and how women's experiences with this "gendered risk" have been folded into their vaccine decision-making.
Drawing on ethnographic fieldwork and archival research, Michelle Wyndham-West explores the creation and circulation of gendered risk as it was deployed in pharmaceutical and policy discourses surrounding the roll-out of the HPV vaccine. The book contextualizes the background for how gendered risk was mediated by two groups of women: mothers negotiating the vaccine for their daughters in school-based immunization programs and university students who experienced frequent HPV infections. The book explores these women's efforts to be good mothers and strong young women entering adulthood who felt vulnerable in sexual health negotiation. As a result, Making Gender reveals how vaccine decision-making took an ontological form, as an inherently social and cultural process embedded in women's experiences.
Sprache
Verlagsort
Zielgruppe
Für höhere Schule und Studium
Für Beruf und Forschung
Produkt-Hinweis
Fadenheftung
Gewebe-Einband
mit Schutzumschlag
Illustrationen
3 b&w figures, 3 b&w tables
Maße
Höhe: 230 mm
Breite: 156 mm
Dicke: 18 mm
Gewicht
ISBN-13
978-1-4875-0920-0 (9781487509200)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
Michelle Wyndham-West is the graduate program director of the Design for Health and Inclusive Design programs and an assistant professor in the Faculty of Design at OCAD University.
Illustrations
Acknowledgments
1. Introduction
2. Navigating Controversies and Doing Mothering: Making HPV Vaccine Decisions for Their Daughters
3. University-Aged Women's Experiences with HPV Infection and Vaccine Decision-Making
4. Media Landscape: Controversies and Competing Narratives
5. Vaccine Marketing by Harnessing Hegemonic Cultural Discourses of Risk and Gender
6. Gendered Vaccine Policymaking
7. Conclusion: Theoretical Contributions and Reassessing Gender-Based Analysis Policymaking
Notes
References
Index